Open AccessThe role of myeloid-derived suppressor cells in hematologic malignancies
Author(s) -
Emine Gulsen Gunes,
Steven T. Rosen,
Christiane Querfeld
Publication year - 2020
Publication title -
current opinion in oncology/current opinion in oncology, with cancerlit
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.297
H-Index - 95
eISSN - 1080-8140
pISSN - 1040-8746
DOI - 10.1097/cco.0000000000000662
Subject(s) - myeloid derived suppressor cell , medicine , immune system , suppressor , immunotherapy , malignancy , tumor microenvironment , cancer research , cancer , immunology , cancer immunotherapy , myeloid , immune tolerance , immune checkpoint
This article focuses on the immunosuppressive impact of myeloid-derived suppressor cells (MDSCs) and the potential clinical implications in hematological malignancies.